Humacyte, Inc. Total Liabilities
Humacyte, Inc. (HUMA) had Total Liabilities of $106.83 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-12
- 2026-06-30: Liabilities $106.83M.
- 2026-03-31: Liabilities $98.93M.
- 2025-12-31: Liabilities $113.26M.
- 2025-09-30: Liabilities $96.26M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $106.83M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $98.93M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $113.26M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $96.26M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $134.74M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $126.51M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $190.54M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $178.49M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $166.57M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $135.31M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $114.68M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $112.39M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $106.99M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $101.09M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $87.37M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $107.55M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $104.11M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $160.58M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $164.36M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $227.50M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $16.81M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $17.26M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $36.02M 10-K · filed 2022-03-29 | $2.10M 10-K · filed 2021-02-16 |
| 2020-09-30 | $1.97M 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |